← All stocks

Vir Biotechnology, Inc.

VIR No buying or selling

CIK 0001706431 #2232 in the set updated 18 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

17 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

SVF Endurance (Cayman) Ltd entity

10% owner

—

13,728,924

$129.74M

−17.7%

SCANGOS GEORGE A

Director

—

1,849,969

$17.48M

−1.1%

SATO VICKI L

Director

—

1,078,391

$10.19M

−18.5%

De Backer Marianne

President and CEO

—

1,001,263

$9.46M

+47.6%

MORE ROBERT J

Director

—

558,573

$5.28M

+2.9%

O'Byrne Jason

EVP & Chief Financial Officer

—

162,615

$1.54M

+5,084%

Eisner Mark

EVP and Chief Medical Officer

—

154,024

$1.46M

+105.4%

HANLY ANN M.

EVP & Chief Technology Officer

—

117,901

$1.11M

−10.7%

de Verneuil Vanina

EVP, General Counsel, Corp Sec

—

112,982

$1.07M

+64.4%

Sabatini Brent

SVP, Chief Accounting Officer

—

61,902

$584.97K

+88.1%

Sigal Charles Elliott

Director

—

39,806

$376.17K

+67.2%

Hatfield Jeffrey S.

Director

—

39,806

$376.17K

+67.2%

Farid Ramy

Director

—

32,000

$302.40K

+100.0%

BISCHOFBERGER NORBERT W

Director

—

32,000

$302.40K

+100.0%

Ramasastry Saira

Director

—

22,619

$213.75K

+54.7%

Napolitano Janet

Director

—

21,216

$200.49K

+82.6%

Coughlin Timothy

Director

—

16,000

$151.20K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Vir Biotechnology, Inc.

By person

Individual transactions

What was left out